Stockscreener 앱 받기
0.2325
4.71%
-0.0115
전일 마감가:
$0.244
열려 있는:
$0.2334
하루 거래량:
737.39K
Relative Volume:
0.06
시가총액:
$2.85M
수익:
$24,000
순이익/손실:
$-78.06M
주가수익비율:
-0.00802
EPS:
-28.9956
순현금흐름:
$-21.81M
1주 성능:
-7.00%
1개월 성능:
+18.50%
6개월 성능:
-56.13%
1년 성능:
-93.82%
1일 변동 폭
$0.231
$0.2369
1주일 범위
$0.2223
$0.28
52주 변동 폭
$0.1648
$4.755
Catheter Precision Inc. Stock (VTAK) Company Profile
명칭
Catheter Precision Inc.
전화
973 691 2000
주소
1670 Highway 160 West, Suite 205, Fort Mill
VTAK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.2325 | 2.85M | 24,000 | -78.06M | -21.81M | -29.00 |
|
ABT
Abbott Laboratories
|
134.44 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.32 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.28 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.39 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-08-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | 개시 | Maxim Group | Buy |
Catheter Precision Inc. 주식(VTAK)의 최신 뉴스
Catheter Precision Inc (VTAK) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Catheter Precision (STU:4RM0) Momentum Rank : 9 (As of Jun. 15, 2025) - GuruFocus
Catheter Precision, Inc. Comments on Recent Market Activity | VT - GuruFocus
Catheter Precision, Inc. Comments on Recent Market Activity - The Manila Times
Catheter Precision, Inc. Addresses Increased Trading Activity in Common Stock - Nasdaq
Catheter Precision, Inc. Comments On Recent Market Activity - Barchart.com
Catheter Precision Issues Urgent Statement on Unexplained Stock Movement, Reveals Strategic Plans - Stock Titan
Catheter Precision (VTAK) Sees Record High Sales for LockeT in Q - GuruFocus
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product | VTAK Stock News - GuruFocus
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product - The Manila Times
Medical Device Breakthrough: Catheter Precision's LockeT Sees 200% Growth, Expands to European Markets - Stock Titan
Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Catheter Precision Inc (VTAK) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga
catheter precision issues stock warrant to ladenburg thalmann By Investing.com - Investing.com Canada
catheter precision issues stock warrant to ladenburg thalmann - Investing.com Australia
Catheter Precision (VTAK) Receives First Order for VIVO from Swe - GuruFocus
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgr - GuruFocus
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital - The Manila Times
Largest Swedish Hospital Chooses Catheter Precision VIVO: Major Win in Scandinavian Cardiac Market - Stock Titan
Catheter Precision Approves Warrant Issuance to Ladenburg - TipRanks
catheter precision announces executive change By Investing.com - Investing.com South Africa
Catheter Precision Announces CCO Departure and Leadership Change - TipRanks
catheter precision announces executive change - Investing.com
Catheter Precision, Inc. Receives Ce Mark for LockeT - marketscreener.com
Catheter Precision (VTAK) Achieves CE Mark Approval for LockeT D - GuruFocus
Catheter Precision Receives CE Mark Approval for LockeT Vascular Closure Device - marketscreener.com
Catheter Precision, Inc. Receives CE Mark for LockeT | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Receives CE Mark Approval for LockeT, Expanding Market Opportunities in Europe - Nasdaq
Catheter Precision, Inc. Receives CE Mark for LockeT - The Manila Times
Catheter Precision Unlocks $4.3B European Market with CE Mark: First Orders Already Flowing - Stock Titan
Catheter Precision, Inc. Receives CE Mark for LockeT | VTAK Stoc - GuruFocus
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Catheter Precision Inc Files For Resale Of Up To 12.9 Million Shares Of Common Stock By The Selling StockholdersSEC Filing - marketscreener.com
Catheter Precision Enters Market Offering Agreement - MSN
Catheter Precision Enters At Market Offering Agreement With Ladenburg Thalmann & Co. IncSEC Filing - marketscreener.com
QHSLab Signals Debt Restructuring - citybiz
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth - TradingView
Breakthrough Patent: How Autonomix Medical's New Nerve-Mapping Tech Could Transform Pain Treatment - Stock Titan
Catheter Precision revenue increases 74% to USD 143K in Q1 2025 - Medical Buyer
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results - The Manila Times
Catheter Precision Q1 Revenue Surges 74% as Clinical Studies Show 94% Accuracy in Heart Procedures - Stock Titan
Catheter Precision Enters Securities Purchase Agreement - TipRanks
Catheter Precision Inc. (VTAK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.19%
자본화:
|
볼륨(24시간):